BRIEF-Vexim says Anvisa approves Spinejack implants in Brazil
* HAS RECEIVED REGULATORY APPROVAL FROM ANVISA(1), BRAZIL'S NATIONAL HEALTH SURVEILLANCE AGENCY, IN ORDER TO COMMERCIALIZE SPINEJACK® IN BRAZIL.
May 1 Huapont Life Science Co Ltd :
* Says it plans to buy 48.3 percent stake in a Lijiang-based tourism firm for totaling 139.4 million yuan, from co's controlling shareholder
Source text in Chinese: goo.gl/mh0AP6
Further company coverage: (Beijing Headline News)
SAO PAULO, May 29 Brazilian healthcare services provider Notre Dame Intermédica Sistema de Saúde SA on Monday filed for regulatory clearance to launch an initial public offering, the latest in a wave of stock listings in Latin America's largest economy after a years-long drought.